MedAbleClinical trials1 / 15Read in the appPitch deck
MedAble's pitch deck
The deck, and the 2 rounds we watched MedAble raise afterwards, with the investors each report named.
Medable is a technology company focused on patient-centric clinical trial execution. Founded in 2012 and headquartered in Palo Alto, California, Medable operates a global cloud-based platform that supports decentralized clinical trials. The company has facilitated over 300 trials across more than 60 countries, serving over 1 million patients. With a workforce of approximately 500 to 650 employees, Medable is recognized as one of America's fastest-growing private companies. The core offering is the Unified Clinical Trial Platform, which includes tools for decentralized trial management, patient engagement, remote monitoring, digital consent, and data integration. Medable's solutions are designed to enhance the efficiency of clinical research and improve patient experiences. The company serves a diverse range of clients, including pharmaceutical and biopharma companies, contract research organizations, and academic medical research centers, all aiming to streamline drug development and advance precision medicine.
Read the deckFree account. The deck belongs to MedAble, so reading it needs one; everything on this page is public.
What is in it
The deck, slide by slide
Each slide by what it argues. 15 slides against a median of 13 across the 1,712 decks we hold.
- 1Cover
- 2Product
- 3Vision
- 4
- 5
- 6Traction
- 7Product
- 8Product
- 9
- 10
- 11
- 12
- 13
- 14Market
- 15Product
CoverProductVisionTractionMarket
What happened next
$304M across 2 rounds
- Oct 2021
- Mar 2015
What they told the regulator
MedAble filed 8 Form Ds with the SEC
The company reporting its own raise, rather than a journalist reporting it.
1 / 15The deck itself
Read MedAble's full pitch deck
All 15 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.
Read the deck →Free account. The deck belongs to MedAble.
Investors who claim them
Firms listing MedAble on their own portfolio page: the firm's own account rather than a round we watched. Weaker than an announcement, much stronger than a list somebody sold us.
Sapphire VenturesVC firm
Streamlined VenturesVC firm
Connectivity Ventures FundVC firmMore decks
SlopeClinical trials1 / 11$50M raised after
CastorClinical trials1 / 9$47M raised after
SpaceXAI1 / 15$42B raised afterBrowse all 1,712 decks. We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, tell us and it goes.